Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature. [electronic resource]
- Expert opinion on therapeutic patents Nov 2017
- 1183-1199 p. digital
Publication Type: Journal Article; Review
1744-7674
10.1080/13543776.2017.1360285 doi
Adenosine Triphosphate--metabolism Alzheimer Disease--drug therapy Animals Cognition Disorders--drug therapy Down Syndrome--drug therapy Drug Design Humans Patents as Topic Protein Kinase Inhibitors--pharmacology Protein Serine-Threonine Kinases--antagonists & inhibitors Protein-Tyrosine Kinases--antagonists & inhibitors Dyrk Kinases